Use of RAAS Inhibitors and Risk of Clinical Deterioration in COVID-19: Results From an Italian Cohort of 133 Hypertensives

The effect of chronic use of renin-angiotensin-aldosterone system (RAAS) inhibitors on the severity of COVID-19 infection is still unclear in patients with hypertension. We aimed to investigate the association between chronic use of angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II...

Celý popis

Podrobná bibliografia

Vydané v:	American journal of hypertension Ročník 33; číslo 10; s. 944
Hlavní autori:	Felice, Carla, Nardin, Chiara, Di Tanna, Gian Luca, Grossi, Ugo, Bernardi, Enrico, Scaldaferri, Luca, Romagnoli, Micaela, Tonon, Luca, Cavasin, Paola, Novello, Simone, Scarpa, Riccardo, Farnia, Antonio, De Menis, Ernesto, Rigoli, Roberto, Cinetto, Francesco, Pauletto, Paolo, Agostini, Carlo, Rattazzi, Marcello
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	21.10.2020
ISSN:	1941-7225, 1941-7225
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!